Article: article d'un périodique ou d'un magazine.
An antigen-targeted approach to adoptive transfer therapy of cancer.
Date de publication
Publication types: Journal Article. - Old month value: May 1
Previous attempts to treat human malignancies by adoptive transfer of tumor-specific CTLs have been limited by the difficulty of isolating T cells of defined antigen specificity. The recent development of MHC class I/antigenic peptide tetrameric complexes that allow direct identification of antigen-specific T cells has opened new possibilities for the isolation and in vitro expansion of tumor-specific T cells. In the present study, we have derived polyclonal monospecific cell lines from circulating Melan-A-specific CTL precursors of HLA-A*0201+ melanoma patients by combining stimulation with recently identified peptide analogues of the immunodominant epitope from the melanoma-associated antigen Melan-A with staining with fluorescent HLA-A*0201/Melan-A peptide tetramers. In vitro expansion of antigen-specific CD8+ T cells was monitored by flow cytometry with the fluorescent tetramers and anti-CD8 monoclonal antibody. This analysis revealed that Melan-A 26-35 peptide analogues were much more efficient than the parental peptides in stimulating a rapid in vitro expansion of antigen-specific CD8+ T cells. These cells were then isolated by tetramer-guided cell sorting and subsequently expanded in vitro by mitogen stimulation. The resulting polyclonal but monospecific CTLs fully cross-recognized the parental peptides and were able to efficiently lyse Melan-A-expressing tumor cells. Altogether, these results pave the way to a molecularly defined approach to antigen-specific adoptive transfer therapy of cancer.
Antigens, Neoplasm/immunology, Biotinylation, Cell Line, Cell Separation, Cytotoxicity, Immunologic, Flow Cytometry, Fluorescent Antibody Technique, Indirect, HLA-A2 Antigen/immunology, Humans, Immunodominant Epitopes/immunology, Immunotherapy, Adoptive, Interleukin-2/pharmacology, Lymphocyte Activation, Macromolecular Substances, Melanoma/blood, Melanoma/immunology, Neoplasm Proteins/immunology, Peptide Fragments/immunology, Recombinant Fusion Proteins/pharmacology, T-Lymphocytes, Cytotoxic/cytology, T-Lymphocytes, Cytotoxic/immunology, Tumor Cells, Cultured
Web of science
Création de la notice
Dernière modification de la notice